SAN FRANCISCO — Glaucoma drainage implants maintain long-term control of IOP in uveitic eyes with fluocinolone acetonide implants, according to a poster presented at the American Glaucoma Society annual meeting.
Jessica L. Cao, MD, of Cole Eye Institute, Cleveland Clinic, and colleagues conducted a retrospective chart review of 56 eyes of 37 patients who had received Retisert (fluocinolone acetonide intravitreal implant, Bausch + Lomb) and had undergone glaucoma drainage implant surgery at the Cleveland Clinic between 2001 and 2017.
Primary outcomes were IOP, visual acuity, number of
Uncategorized